Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;37(10):e15085.
doi: 10.1111/ctr.15085. Epub 2023 Aug 7.

Evolving challenges with long-term care of liver transplant recipients

Affiliations
Review

Evolving challenges with long-term care of liver transplant recipients

Matthew A Odenwald et al. Clin Transplant. 2023 Oct.

Abstract

The number of liver transplants (LT) performed worldwide continues to rise, and LT recipients are living longer post-transplant. This has led to an increasing number of LT recipients requiring lifelong care. Optimal care post-LT requires careful attention to both the allograft and systemic issues that are more common after organ transplantation. Common causes of allograft dysfunction include rejection, biliary complications, and primary disease recurrence. While immunosuppression prevents rejection and reduces incidences of some primary disease recurrence, it has detrimental systemic effects. Most commonly, these include increased incidences of metabolic syndrome, various malignancies, and infections. Therefore, it is of utmost importance to optimize immunosuppression regimens to prevent allograft dysfunction while also decreasing the risk of systemic complications. Institutional protocols to screen for systemic disease and heightened clinical suspicion also play an important role in providing optimal long-term post-LT care. In this review, we discuss these common complications of LT as well as unique considerations when caring for LT recipients in the years after transplant.

Keywords: allograft rejection; biliary complications; immunosuppression; liver transplant; post-transplant infection; post-transplant malignancy; post-transplant metabolic syndrome.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Moon AM, Singal AG, Tapper EB. contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol H. 2019;18:2650-2666.
    1. Younossi ZM, Stepanova M, Younossi Y, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69:564.
    1. Termeie O, Fiedler L, Martinez L, et al. Alarming trends: mortality from alcoholic cirrhosis in the United States. Am J Med. 2022;135(10):1263-1266. 10.1016/j.amjmed.2022.05.015
    1. Sepanlou SG, Safiri S, Bisignano C, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:245-266.
    1. Starzl TE, Iwatsuki S, Van Thiel DH, et al. Evolution of liver transplantation. Hepatology. 1982;2:614S-636S.

LinkOut - more resources